Conversely, significant upregulation of MCC was observed in the following three cancer types: glioblastoma multiforme (GBM), pancreatic adenocarcinoma (PAAD), and thymoma (THYM). This evidence concerns the gene MCC and pancreatic adenocarcinoma.